Fifteen-year follow-up of thyroid function in lithium patients

Journal of Endocrinological Investigation

Volumn 30, Issue 5, 2007, Pages 363-366

  Bocchetta, A ^a   Cocco, F ^a   Velluzzi, F ^a   Del Zompo, M ^a   Mariotti, S ^a   Loviselli, A ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Bipolar disorders; Hypothyroidism; Lithium; Thyroid antibodies

Indexed keywords

IODINE 131; LEVOTHYROXINE; LITHIUM; MICROSOME ANTIBODY; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; AUTOANTIBODY; LITHIUM CARBONATE; THYROID STIMULATING IMMUNOGLOBULIN; THYROXINE; TRANQUILIZER;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; FOLLOW UP; GOITER; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; SIDE EFFECT; THYROID CANCER; THYROID DISEASE; TREATMENT DURATION; AGED; BLOOD; CHEMICALLY INDUCED DISORDER; EPIDEMIOLOGY; IMMUNOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS; THYROID GLAND; THYROID TUMOR; THYROIDECTOMY;

AGED; ANTIMANIC AGENTS; AUTOANTIBODIES; CARCINOMA, PAPILLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOGLOBULINS, THYROID-STIMULATING; INCIDENCE; LITHIUM CARBONATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; THYROXINE;

EID: 34447642865     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346311     Document Type: Article

References (20)

1. Schou M, Amdisen A, Jensen S, Olsen T. Occurrence of goiter during lithium treatment. BMJ 1968, 3: 710-3.
2. Lazarus JH. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 1998, 8: 909-13.
3. Bocchetta A, Loviselli A. Lithium treatment and thyroid abnormalities. Clin Pract Epidemol Ment Health 2006, 2: 23.
4. Bocchetta A, Bernardi F, Pedditzi M, et al. Thyroid abnormalities during lithium treatment. Acta Psychiatr Scand 1991, 83: 193-8.
5. Bocchetta A, Bernardi F, Burrai C, et al. The course of thyroid abnormalities during lithium treatment: a two-year follow-up study. Acta Psychiatr Scand 1992, 86: 38-41.
6. Bocchetta A, Cherchi A, Loviselli A, et al. Six-year follow-up of thyroid function during lithium treatment. Acta Psychiatr Scand 1996, 94: 45-8.
7. Bocchetta A, Mossa P, Velluzzi F, Mariotti S, Del Zompo M, Loviselli A. Ten-year follow-up of thyroid function in lithium patients. J Clin Psychopharmacol 2001, 21: 594-8.
8. Nemeroff CB, Simon JS, Haggerty JJ Jr, Evans DL. Antithyroid antibodies in depressed patients. Am J Psychiatry 1985, 142: 840-3.
9. Haggerty JJ Jr, Prange AJ Jr. Borderline hypothyroidism and depression. Annu Rev Mad 1995, 46: 37-46.
10. Kupka RW, Nolen WA, Post RM, et al. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry 2002, 51: 305-11.
11. Tunbridge WMG, Brewis M, French JM, et al. Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) 1981, 282: 258-62.
12. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995, 43: 55-68.
13. Martino E, Loviselli A, Velluzzi F, et al. Endemic goiter and thyroid function in central-southern Sardinia: report on an extensive epidemiological survey. J Endocrinol Invest 1994, 17:653-7.
14. Loviselli A, Oppo A, Velluzzi F, et al. Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western Sardinia. J Endocrinol Invest 1999, 22: 660-5.
15. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry 1999, 175: 336-9.
16. Kirov G, Tredget J, John R, Owen MJ, Lazarus JH. A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients. J Affect Disord 2005, 87: 313-7.
17. Miller KK, Daniels GH. Association between lithium use and thyrotoxicosis caused by silent thyroiditis. Clin Endocrinol (Oxf) 2001, 55: 501-8.
18. Martino E, Placidi GF, Sardano G, et al. High incidence of goiter in patientstreated with lithium carbonate. Ann Endocrinol (Paris) 1982, 43: 269-76.
19. Lazarus JH. Is thyroxine during lithium therapy necessary? J Endocrinol Invest 1998, 21: 784-6.
20. Bartalena L, Bogazzi F, Martino E. Is thyroxine during lithium therapy necessary? J Endocrinol Invest 1999, 22: 220-2.